SUPRIYA LIFESCIENCE Latest Share Price (SUPRIYA)
TODAY IN ONE LINE
SUPRIYA fell 1.7% on light volume, lagging Nifty's -0.3% move.
With a market cap of ₹7,243.45 Cr., it trades at a P/E of 36.51. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SUPRIYA LIFESCIENCE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 46.7% YoY
- ●High Capital EfficiencyROCE of 18.1% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 17.5%
- ●Healthy Operating MarginsOPM is structurally strong at 33.4%
- ●High Promoter HoldingPromoters hold 68.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●FII AccumulationFII holding increased by 1.03% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 31.4% YoY
Latest SUPRIYA LIFESCIENCE News
What changed recently?
Recent events, corporate actions, and announcements.
SUPRIYA LIFESCIENCE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SUPRIYA LIFESCIENCE, framed against the sector median so the premium or discount is obvious at a glance.
SUPRIYA LIFESCIENCE trades at a P/E of 36.51× and P/B of 6.05×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SUPRIYA LIFESCIENCE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SUPRIYA LIFESCIENCE — derived from the latest tape, not yesterday's close.
SUPRIYA LIFESCIENCE last traded at ₹901.75 with an intraday range of ₹891.25–₹915.3 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹901.75| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 962.38 | +60.63 | +6.72% |
| R3 | 938.33 | +36.58 | +4.06% |
| R2 | 926.82 | +25.07 | +2.78% |
| R1 | 914.28 | +12.53 | +1.39% |
| PIVOT | 902.77 | 1.02 | 0.11% |
| CURRENT | 901.75 | — | — |
| S1 | 890.23 | -11.52 | -1.28% |
| S2 | 878.72 | -23.03 | -2.55% |
| S3 | 866.18 | -35.57 | -3.94% |
| S4 | 842.13 | -59.62 | -6.61% |
SUPRIYA is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹897.75–₹915.3
Trading Below opening range, showing Bearishness
SUPRIYA LIFESCIENCE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SUPRIYA LIFESCIENCE — consolidated or standalone — with margins, YoY growth and key ratios inline.
SUPRIYA LIFESCIENCE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹7,243.45 Cr. and reported EPS of ₹2.99.
SUPRIYA LIFESCIENCE segment analysis : revenue and profit mix.
Disclosed business segments at SUPRIYA LIFESCIENCE with their share of revenue and profit, switchable between consolidated and standalone reporting.
SUPRIYA LIFESCIENCE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SUPRIYA LIFESCIENCE.
Our AI distills the core fundamental drivers supporting SUPRIYA LIFESCIENCE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
SUPRIYA LIFESCIENCE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 47 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 12% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.06%.
SUPRIYA LIFESCIENCE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SUPRIYA LIFESCIENCE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
SUPRIYA LIFESCIENCE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SUPRIYA LIFESCIENCE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SUPRIYA LIFESCIENCE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SUPRIYA LIFESCIENCE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SUPRIYA LIFESCIENCE stood at 42.9% of traded volume, against a 20-day average of 44.2%.
SUPRIYA LIFESCIENCE announcements: results, concalls, ratings, M&A.
Filings SUPRIYA LIFESCIENCE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
SUPRIYA LIFESCIENCE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 132 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Supriya Lifescience Limited has informed the Exchange about Schedule of meet
General Updates
Supriya Lifescience Limited has informed the Exchange about General Updates
General Updates
Supriya Lifescience Limited has informed the Exchange about General Updates
Copy of Newspaper Publication
Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication
Clarification - Financial Results
The Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
SUPRIYA LIFESCIENCE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SUPRIYA LIFESCIENCE has declared, sequenced by announce and record date.
SUPRIYA LIFESCIENCE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About SUPRIYA LIFESCIENCE: business, sector, key facts.
What SUPRIYA LIFESCIENCE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SUPRIYA LIFESCIENCE operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: SUPRIYA, BSE: 543434.
Supriya Lifescience Limited is a global player in the pharmaceutical industry, specializing in the research, development, manufacturing, and sale of bulk drugs and pharmaceutical chemicals. Their primary focus is on the creation and distribution of Active Pharmaceutical Ingredients (APIs) used in a wide range of therapeutic areas.
The company's API portfolio encompasses various therapeutic segments including anti-histamines, anti-allergics, anti-asthmatics, decongestants, analgesics, antipyretics, anesthetics, anti-hypertensives, anti-malarials, vitamins, and products for treating gout. They also cater to the oncology, veterinary, and general pharmaceutical markets with a diverse range of products.
Beyond their core API business, Supriya Lifescience has expanded into the development and commercialization of specialized healthcare products. This includes GelHeal, a wound care solution, and Quickblue, a kit for the early detection of oral cancer. This diversification demonstrates their commitment to addressing a broader spectrum of healthcare needs.
Looking towards the future, Supriya Lifescience is actively engaged in the research and development of novel drugs across numerous therapeutic areas. Their pipeline includes potential treatments for depression, inflammation, various types of cancers, diabetes, obesity, migraine, and ataxia. They are also exploring opportunities in the development of contrast media, hormones, antibiotics, smoking cessation aids, and veterinary APIs. This aggressive R&D strategy signifies their commitment to innovation and expansion within the pharmaceutical landscape.
Established in 1987 and headquartered in Mumbai, India, Supriya Lifescience has a long history of serving the global pharmaceutical market. Their integrated approach, combining research, manufacturing, and sales, allows them to maintain a strong position in the competitive pharmaceutical industry and continue to explore new avenues for growth and development.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AAREY DRUGS & PHARM (AAREYDRUGS) Share PricePeer
- AARTI DRUGS (AARTIDRUGS) Share PricePeer
- AARTI PHARMALABS (AARTIPHARM) Share PricePeer
- AJANTA PHARMA (AJANTPHARM) Share PricePeer
- AKUMS DRUGS AND PHARMA L (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about SUPRIYA LIFESCIENCE (SUPRIYA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SUPRIYA LIFESCIENCE (SUPRIYA)?
The current share price of SUPRIYA LIFESCIENCE (SUPRIYA) is ₹901.75. Today, the stock has declined by ₹15.70 (1.71%), trading in a range of ₹891.25 to ₹915.30. The stock opened at ₹915.00 with a trading volume of 2,08,583 shares.
02Is SUPRIYA LIFESCIENCE stock a good investment for long-term?
SUPRIYA LIFESCIENCE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹7,243.45 Cr., P/E ratio of 36.51, ROE of 17.46%, and ROCE of 18.15%. The dividend yield stands at 0.11%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of SUPRIYA LIFESCIENCE stock?
The 52-week high price of SUPRIYA LIFESCIENCE (SUPRIYA) is ₹1,085.00, while the 52-week low is ₹545.50. Currently trading at ₹901.75, the stock is 65.31% above its 52-week low and 16.89% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy SUPRIYA LIFESCIENCE stock at the current price?
Whether to buy SUPRIYA LIFESCIENCE stock at ₹901.75 depends on multiple factors. The stock is currently trading with a P/E ratio of 36.51 and P/B ratio of 6.05. Today's performance shows a loss of 1.71%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of SUPRIYA LIFESCIENCE and when is the next dividend?
SUPRIYA LIFESCIENCE offers a dividend yield of 0.11%, which means for every ₹100 invested at the current price of ₹901.75, you can expect to receive approximately ₹0.11 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of SUPRIYA LIFESCIENCE?
SUPRIYA LIFESCIENCE's key financial metrics include: P/E Ratio: 36.51, P/B Ratio: 6.05, ROE: 17.46%, ROCE: 18.15%, Dividend Yield: 0.11%, EPS: ₹2.99, Book Value: ₹148.82, and Debt-to-Equity: 0. The company's market cap stands at ₹7,243.45 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is SUPRIYA LIFESCIENCE stock performing today in the market?
SUPRIYA LIFESCIENCE stock opened at ₹915.00 and is currently trading at ₹901.75, showing a decline of ₹15.70 (1.71%). The intraday high is ₹915.30 and low is ₹891.25. The trading volume stands at 2,08,583 shares, indicating moderate market participation today.
08What is the P/E ratio of SUPRIYA LIFESCIENCE and what does it indicate?
SUPRIYA LIFESCIENCE has a Price-to-Earnings (P/E) ratio of 36.51, which means investors are willing to pay 36.51 for every ₹1 of earnings. With an EPS of ₹2.99, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about SUPRIYA LIFESCIENCE (SUPRIYA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.